RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic

L Tian, T Qiang, C Liang, X Ren, M Jia, J Zhang… - European journal of …, 2021 - Elsevier
The widespread nature of several viruses is greatly credited to their rapidly altering RNA
genomes that enable the infection to persist despite challenges presented by host cells …

Flavonoids: A complementary approach to conventional therapy of COVID-19?

J Solnier, JP Fladerer - Phytochemistry Reviews, 2021 - Springer
COVID-19, the highly contagious novel disease caused by SARS-CoV-2, has become a
major international concern as it has spread quickly all over the globe. However, scientific …

Antiviral activity of four types of bioflavonoid against dengue virus type-2

K Zandi, BT Teoh, SS Sam, PF Wong, MR Mustafa… - Virology journal, 2011 - Springer
Background Dengue is a major mosquito-borne disease currently with no effective antiviral
or vaccine available. Effort to find antivirals for it has focused on bioflavonoids, a plant …

Current trends and limitations in dengue antiviral research

JO Obi, H Gutiérrez-Barbosa, JV Chua… - Tropical Medicine and …, 2021 - mdpi.com
Dengue is the most prevalent arthropod-borne viral disease worldwide and affects
approximately 2.5 billion people living in over 100 countries. Increasing geographic …

Current status of dengue therapeutics research and development

JGH Low, EE Ooi, SG Vasudevan - The Journal of infectious …, 2017 - academic.oup.com
Dengue is a significant global health problem. Even though a vaccine against dengue is
now available, which is a notable achievement, its long-term protective efficacy against each …

[HTML][HTML] Recent advances in antiviral drug development towards dengue virus

B Troost, JM Smit - Current opinion in virology, 2020 - Elsevier
Highlights•Evaluating drug efficacy, specificity and toxicity may help to develop an optimal
treatment regime for in vivo studies.•Measuring time to resolve viremia in vivo may help to …

Molecular mechanisms of antiviral agents against dengue virus

MF Lee, YS Wu, CL Poh - Viruses, 2023 - mdpi.com
Dengue is a major global health threat causing 390 million dengue infections and 25,000
deaths annually. The lack of efficacy of the licensed Dengvaxia vaccine and the absence of …

Animal models of dengue virus infection

S Zompi, E Harris - Viruses, 2012 - mdpi.com
The development of animal models of dengue virus (DENV) infection and disease has been
challenging, as epidemic DENV does not naturally infect non-human species. Non-human …

Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus

M Tahir ul Qamar, A Maryam, I Muneer, F Xing… - Scientific reports, 2019 - nature.com
Emergence of Dengue as one of the deadliest viral diseases prompts the need for
development of effective therapeutic agents. Dengue virus (DV) exists in four different …

The medicinal chemistry of dengue virus

MAM Behnam, C Nitsche, V Boldescu… - Journal of medicinal …, 2016 - ACS Publications
The dengue virus and related flaviviruses are an increasing global health threat. In this
perspective, we comment on and review medicinal chemistry efforts aimed at the prevention …